How should iron‑deficiency anemia with low ferritin be evaluated and managed?

Evaluation and Management of Iron Deficiency Anemia with Low Ferritin

Iron deficiency anemia with low ferritin requires gastrointestinal evaluation in most adults, immediate iron replacement therapy, and investigation for underlying causes—particularly occult GI bleeding and malabsorption disorders.

Diagnostic Confirmation

Diagnose iron deficiency anemia when ferritin is <45 ng/mL in patients with anemia, as this threshold provides optimal sensitivity and specificity 1, 2.

• In patients with concurrent inflammation, chronic kidney disease, or chronic heart failure, ferritin may be falsely elevated; consider iron deficiency even with ferritin between 45-100 ng/mL if transferrin saturation is <20% 1, 3.
• Additional confirmatory tests include transferrin saturation <16-20%, which indicates functional iron deficiency 1, 2.
• In inflammatory conditions, ferritin <100 ng/mL is diagnostic of iron deficiency, while ferritin 30-100 ng/mL with transferrin saturation <16% suggests combined iron deficiency and anemia of chronic disease 1.

Gastrointestinal Evaluation

For asymptomatic postmenopausal women and men with iron deficiency anemia, perform bidirectional endoscopy (both upper endoscopy and colonoscopy) as the primary diagnostic approach 1.

• Upper GI endoscopy reveals a cause in 30-50% of patients and should include small bowel biopsies to screen for celiac disease, which accounts for 2-3% of iron deficiency anemia cases 1.
• For asymptomatic premenopausal women, bidirectional endoscopy is suggested over iron replacement alone, though younger patients with plausible causes (heavy menstrual bleeding) may reasonably start with iron therapy and observation 1, 2.
• Perform noninvasive testing for Helicobacter pylori infection, followed by treatment if positive, as this is a recognized cause of iron malabsorption 1, 4.
• Test for celiac disease with serologic testing first; proceed to small bowel biopsy only if serology is positive 1.
• If both upper endoscopy and colonoscopy are normal and anemia persists despite oral iron therapy, investigate the small bowel with capsule endoscopy 1, 5.

Iron Replacement Therapy

Initiate oral iron supplementation as first-line therapy for most patients with iron deficiency anemia 1, 2.

Oral Iron Administration

• Prescribe ferrous sulfate, ferrous fumarate, or ferrous gluconate at doses providing 3-6 mg/kg elemental iron daily 1, 3.
• Administer oral iron every other day rather than daily, as this improves absorption by avoiding hepcidin upregulation 1.
• Take iron on an empty stomach when possible; if not tolerated, take with meals containing meat protein and 500 mg vitamin C to enhance absorption 1.
• Avoid taking iron with calcium-containing foods or fiber unless vitamin C is also present 1.
• Reassess hemoglobin in 2-4 weeks; expect an increase of ≥1 g/dL if treatment is effective 3, 2.
• Continue oral iron for 3 months after hemoglobin normalizes to replenish iron stores 3.

Intravenous Iron Indications

Switch to intravenous iron if oral iron is not tolerated, absorption is impaired, or there is no hemoglobin response after 2-4 weeks of adequate oral therapy 1, 2.

• Intravenous iron is preferred in patients with inflammatory bowel disease, chronic heart failure, or chronic kidney disease where oral absorption is compromised 1, 4.
• Available IV formulations include ferric carboxymaltose (up to 750 mg per dose, maximum 1,500 mg total), iron sucrose (200 mg twice weekly), and low molecular weight iron dextran 1, 6, 7.
• Ferric carboxymaltose increases hemoglobin by mean 1.6 g/dL in oral iron-intolerant patients and 2.9 g/dL in those with unsatisfactory oral response 6.
• Iron sucrose effectively corrects ferritin levels (from ~10 ng/mL to ~224 ng/mL) and hemoglobin (from ~8 g/dL to ~11.2 g/dL) after one month of treatment 8.
• Hypersensitivity reactions to newer IV iron formulations occur in <1% of patients 2.
• Monitor for potential adverse effects including hypophosphatemia, allergic reactions, and iron overload with high-dose IV formulations 4.

Common Pitfalls to Avoid

• Do not assume normal ferritin excludes iron deficiency in patients with inflammation—ferritin is an acute phase reactant and can be falsely elevated 1, 3.
• Do not rely solely on serum iron levels, as they have significant diurnal variation and low specificity 3.
• Do not stop anticoagulants or NSAIDs before completing GI evaluation, though discontinuing NSAIDs is recommended once evaluation is complete 1.
• Do not assume dietary insufficiency or menstrual bleeding is the sole cause without GI investigation in postmenopausal women and men 1.
• Do not perform routine gastric biopsies for atrophic gastritis unless clinically indicated 1.

Special Populations

• In patients with celiac disease and iron deficiency anemia, ensure strict adherence to a gluten-free diet to improve iron absorption before escalating to IV iron 1.
• In chronic kidney disease patients, target transferrin saturation >20% and ferritin 100-500 ng/mL for optimal erythropoiesis 1.
• In heart failure patients with iron deficiency (ferritin <100 ng/mL or ferritin 100-300 ng/mL with transferrin saturation <20%), IV iron improves exercise capacity and quality of life regardless of anemia presence 6.